About the Breast Cancer Susceptibility Gene 1 Ovarian Cancer

>
>

SANTA MONICA, Calif.—-The Prostate Cancer Foundation today announced that it has funded twelve new Creativity Awards to support innovative projects because of their potential to fast-forward discovery and deliver game-changing results for prostate cancer research.

>
>

EntreMed, Inc., today announced the addition of Dana Farber/Harvard Cancer Center (DF/HCC) to the Phase 2 multi-center study entitled “A Phase 2 Study of Oral ENMD-2076 Administered to Patients with Platinum Resistant Ovarian Cancer.” Ursula Matulonis, M.D., Associate Professor of Medicine, Dana-Farber Cancer Institute and Harvard Medical School, will serve as principal investigator.